• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Transitions and MLB legend Cal Ripken, Jr., provide healthy vision for underserved children

Article

 

Pinellas Park, FL-Healthy vision is now a reality for hundreds of children in need across the country, thanks to Transitions Optical and MLB Hall of Famer and baseball legend Cal Ripken, Jr., along with the Cal Ripken, Sr. Foundation.

“Being a Transitions lenses wearer and partnering with Transitions Optical, I’ve become passionate about spreading the word, especially to children and families across the country about how important it is to take care of your eyes and the difference that care will make in a child’s future,” said Cal Ripken, Jr.

Hundreds of children from Boys and Girls Clubs and YMCA centers in the southeastern U.S. received comprehensive eye exams on board Eyenstein, Transitions Optical and VSP Vision Care’s mobile eyecare clinic. If prescription eyeglasses were needed, children could choose a new pair of eyeglass frames fitted with Transitions lenses. Approximately one-third of the children examined required prescription eyewear, a higher rate than the American Public Health Association average statistic-that one in four children has an undiagnosed vision problem that can interfere with the ability to read and learn.

In addition, Cal Ripken, Jr. led baseball clinics at each Eyenstein event, with multiple skills stations to demonstrate how healthy, enhanced vision impacts performance on the field.

Related Videos
Charles Leclercq, CEO of ARxVision, details the new ARx AI headset and its uses
© 2024 MJH Life Sciences

All rights reserved.